Farther Finance Advisors, LLC

Position in ABT — Abbott Laboratories

CIK 1992825 SAN FRANCISCO, CA

Position in ABT

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$7,476,224

-$310,549 QoQ

Shares Held

72,818

+17.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $25,381,241 across 88 Medical Devices names. ABT ranks #1 (29.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories This page	72,818	$7,476,224
2	SYK	Stryker Corp	17,084	$5,613,631
3	MDT	Medtronic plc	59,342	$5,141,984
4	BSX	Boston Scientific Corp	22,272	$1,397,568
5	EW	Edwards Lifesciences Corp	14,039	$1,124,243
6	STE	STERIS plc	3,208	$709,385
7	GEHC	GE HealthCare Technologies Inc.	9,046	$643,894
8	DXCM	Dexcom Inc	9,960	$625,488

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,476,224	72,818	+17.2%	Shares	Sole	2026-04-07
2025-12-31	$7,786,773	62,150	+45.4%	Shares	Sole	2026-01-23
2025-09-30	$5,724,595	42,740	+8.2%	Shares	Sole	2025-10-14
2025-06-30	$5,371,170	39,491	+19.7%	Shares	Sole	2025-07-11
2025-03-31	$4,378,113	33,005	+45.1%	Shares	Sole	2025-04-14
2024-12-31	$2,572,121	22,740	+9.8%	Shares	Sole	2025-02-10
2024-09-30	$2,361,603	20,714	+12.5%	Shares	Sole	2024-10-29
2024-06-30	$1,912,567	18,406	+15.6%	Shares	Sole	2024-07-31
2024-03-31	$1,809,239	15,918	+23.0%	Shares	Sole	2024-05-14
2023-12-31	$1,424,746	12,944	+40.2%	Shares	Sole	2024-02-15
2023-09-30	$894,119	9,232	+12.2%	Shares	Sole	2023-11-14
2023-06-30	$897,343	8,231	+89.3%	Shares	Sole	2024-05-14
2023-03-31	$440,177	4,347	+0.6%	Shares	Sole	2024-05-14
2022-12-31	$474,292	4,320	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.